These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3285669)

  • 41. Evaluation of a confidential method of excluding blood donors exposed to human immunodeficiency virus.
    Nusbacher J; Chiavetta J; Naiman R; Buchner B; Scalia V; Herst R
    Transfusion; 1986; 26(6):539-41. PubMed ID: 3535180
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diagnosis of human immunodeficiency virus infection in seronegative homosexuals presenting with an acute viral syndrome.
    Kessler HA; Blaauw B; Spear J; Paul DA; Falk LA; Landay A
    JAMA; 1987 Sep; 258(9):1196-9. PubMed ID: 3306009
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of an enzyme immunoassay for detection of antibody to human immunodeficiency virus in low risk populations.
    Peetoom F
    Transfusion; 1986; 26(6):536-8. PubMed ID: 3535179
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of the concomitant use of two different EIA tests for HIV screening in blood banks.
    Otani MM; Salles NA; Barreto AM; Barreto CC; Chamone DF; Sabino EC
    Rev Panam Salud Publica; 2003; 13(2-3):172-5. PubMed ID: 12744793
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An automated screening test for antibodies to human immunodeficiency virus-1.
    Sekiguchi S; Ikeda H; Kato T; Maeda R; Fukai K
    Transfusion; 1988; 28(6):581-5. PubMed ID: 3057684
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Utility of quantitative enzyme immunoassay reactivity for predicting human immunodeficiency virus seropositivity in low- and high-prevalence populations.
    Hou X; Breese PL; Douglas JM
    J Clin Microbiol; 1994 Jan; 32(1):220-3. PubMed ID: 8126185
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A new second-generation anti-HIV-1 enzyme immunoassay using recombinant envelope and core proteins.
    Bäcker U; Gathof A; Howe J; Strobel E; Deinhardt F; Gürtler L; Grob P; Joller-Jemelka H; Kühnl P; Seidl S
    AIDS; 1988 Dec; 2(6):477-80. PubMed ID: 3149495
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Performance evaluation of the Bio-Rad Laboratories GS HIV Combo Ag/Ab EIA, a 4th generation HIV assay for the simultaneous detection of HIV p24 antigen and antibodies to HIV-1 (groups M and O) and HIV-2 in human serum or plasma.
    Bentsen C; McLaughlin L; Mitchell E; Ferrera C; Liska S; Myers R; Peel S; Swenson P; Gadelle S; Shriver MK
    J Clin Virol; 2011 Dec; 52 Suppl 1():S57-61. PubMed ID: 21995929
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Screening for human immunodeficiency virus antibody in urine.
    Berrios DC; Avins AL; Haynes-Sanstad K; Eversley R; Woods WJ
    Arch Pathol Lab Med; 1995 Feb; 119(2):139-41. PubMed ID: 7848060
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection of early anti-p24 HIV responses in EIA- and immunoblot-negative individuals. Implications for confirmatory testing.
    Huisman JG; Winkel IN; Lelie PN; Tersmette M; Goudsmit J; Miedema F
    Vox Sang; 1987; 53(1):31-6. PubMed ID: 3310400
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reduced frequency of blood donors with false-positive HIV-1 and -2 antibody EIA reactivity after elution of low-affinity nonspecific natural antibodies.
    Bouillon M; Aubin E; Roberge C; Bazin R; Lemieux R
    Transfusion; 2002 Aug; 42(8):1046-52. PubMed ID: 12385417
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of Multispot EIA with Western blot for confirmatory serodiagnosis of HIV.
    Torian LV; Forgione LA; Punsalang AE; Pirillo RE; Oleszko WR
    J Clin Virol; 2011 Dec; 52 Suppl 1():S41-4. PubMed ID: 21995935
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Field evaluation of rapid HIV serologic tests for screening and confirming HIV-1 infection in Honduras.
    Stetler HC; Granade TC; Nunez CA; Meza R; Terrell S; Amador L; George JR
    AIDS; 1997 Mar; 11(3):369-75. PubMed ID: 9147429
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk factors for repeatedly reactive HIV-1 EIA and indeterminate western blots. A population-based case-control study.
    Celum CL; Coombs RW; Jones M; Murphy V; Fisher L; Grant C; Corey L; Inui T; Wener MH; Holmes KK
    Arch Intern Med; 1994 May; 154(10):1129-37. PubMed ID: 7910452
    [TBL] [Abstract][Full Text] [Related]  

  • 55. What do western blot indeterminate patterns for human immunodeficiency virus mean in EIA-negative blood donors?
    Genesca J; Shih JW; Jett BW; Hewlett IK; Epstein JS; Alter HJ
    Lancet; 1989 Oct; 2(8670):1023-5. PubMed ID: 2572749
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human immunodeficiency virus and human T-cell leukemia virus type I in patients undergoing maintenance hemodialysis in Miami.
    Perez G; Ortiz-Interian C; Lee H; de Medina M; Cerney M; Allain JP; Schiff E; Parks E; Parks W; Bourgoignie JJ
    Am J Kidney Dis; 1989 Jul; 14(1):39-43. PubMed ID: 2787117
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Longitudinal follow-up of blood donors found to be reactive for antibody to human immunodeficiency virus (anti-HIV) by enzyme-linked immunoassay (EIA+) but negative by western blot (WB-).
    Nusbacher J; Naiman R
    Transfusion; 1989 May; 29(4):365-7. PubMed ID: 2655209
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HLA antibodies as a cause of false-positive reactions in screening enzyme immunoassays for antibodies to human T-lymphotropic virus type III.
    Sayers MH; Beatty PG; Hansen JA
    Transfusion; 1986; 26(1):113-5. PubMed ID: 3003973
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of the Bio-Rad Geenius HIV-1/2 test as a confirmatory assay.
    Montesinos I; Eykmans J; Delforge ML
    J Clin Virol; 2014 Aug; 60(4):399-401. PubMed ID: 24932737
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors.
    Busch MP; Lee LL; Satten GA; Henrard DR; Farzadegan H; Nelson KE; Read S; Dodd RY; Petersen LR
    Transfusion; 1995 Feb; 35(2):91-7. PubMed ID: 7825218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.